
SAINT neuromodulation rapidly eases severe depression, enabling therapy and recovery in days; personalized targeting boosts outcomes, while access grows and suicide data remains limited.

SAINT neuromodulation rapidly eases severe depression, enabling therapy and recovery in days; personalized targeting boosts outcomes, while access grows and suicide data remains limited.

SAINT uses brain imaging-guided TMS to deliver rapid, intensive sessions, helping treatment-resistant depression patients reach remission faster than conventional protocols.

MRI-guided SAINT TMS aims to remit treatment-resistant depression in days.

September 30th 2026